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Abstract.  Spreading of neutrophils on protein-coated 
surfaces is a pivotal event in their ability to respond 
to soluble, physiologic agonists by releasing large 
amounts of hydrolases and oxidants. Using neutrophils 
plated on serum-, fibrinogen- or fibronectin-coated 
surfaces, we investigated the effect of human serum al- 
bumin (HSA) on spreading-dependent neutrophil re- 
sponses. HSA suppressed the respiratory burst of neu- 
trophils in response to tumor necrosis factor-or (TNF), 
complement component C5a or formylated peptide, 
but not phorbol myristate acetate. HSA was suppres- 
sive only if added before the onset of the respiratory 
burst, and suppression was reversed when HSA was 
removed. Likewise, HSA selectively and reversibly in- 
hibited TNF-induced cell spreading and the associated 
fall in cAMP. However, HSA did not hinder TNF- 
induced cell adherence to the same protein-coated sur- 
faces. 
We investigated cell surface sialoproteins as modula- 
tors of cell spreading and as targets for the anti- 
spreading action of HSA. Oxidation of the cell surface 
with periodate followed by reduction with 3H-boro- 
hydride and immunoblotting with specific mAbs 
helped identify the predominant sialoprotein on human 
neutrophils as CD43  (sialophorin, leukosialin). Treat- 
ment of neutrophils with C  perfringens sialidase 
desialylated CD43, markedly enhanced the ability of 
the cells to respond to TNF by spreading and under- 
going a respiratory burst, and antagonized the ability 
of HSA to inhibit these responses. TNF-treated, ad- 
herent neutrophils shed CIM3, and this was blocked 
by HSA, but not by ovalbumin. Exogenous neutrophil 
elastase removed CD43 from the neutrophil surface. 
HSA blocked the actions of both sialidase and elastase 
on CD43.  In contrast, ovalbumin did not block the ac- 
tion of sialidase on CD43, and HSA did not inhibit 
the ability of sialidase to hydrolyze a synthetic sub- 
strate. These results suggested that HSA might bind 
CD43.  In fact, the extracellular portion of CD43 
bound to HSA-Sepharose, but not to ovalbumin- or 
glycylglycine-Sepharose. Finally, two mAbs recogniz- 
ing different epitopes on CD43 mimicked HSgs in- 
hibitory effects on neutrophil function. 
Thus, HSA can dissociate attachment of neutrophils 
from spreading. This dissociation may help neutrophils 
migrate along a chemotactic gradient, while decreas- 
ing their release of oxidants. CIM3, a long, rigid mol- 
ecule with a markedly negative charge, antagonizes 
neutrophil spreading. HSA appears to inhibit 
spreading-dependent neutrophil functions by binding to 
CD43 and interfering with the ability of neutrophils to 
shed it. 
T 
HE anti-infectious and pro-inflammatory functions of 
neutrophils are usually discharged after the cells have 
stopped circulating and have adhered to each other or 
to platelets, endothelium, parenchyma, stromal cells, or pro- 
teins of extracellular matrix. This has motivated a number 
of investigators to explore the biology of neutrophils adher- 
ent to model biological surfaces. A simple model consists of 
neutrophils plated on plastic or glass coated with plasma, se- 
rum, fibrinogen, fibronectin, vitronectin, laminin, or throm- 
bospondin  (12, 18, 23, 30, 31, 33,  39-42,  54,  63, 65), or 
bearing a confluent monolayer of endothelial cells (39) or 
myocytes (15). A major finding to emerge from such studies 
is that soluble, physiologic poly- or oligopeptides such as tu- 
mor  necrosis  factor  (TNF)~-c~, granulocyte-macrophage 
colony-stimulating factor (GM-CSF),  macrophage inflam- 
matory protein-1 (MIP-1), interleukin-8  (IL-8),  C5a,  and 
formylated methionylleucylphenylalanine (fMLF) act as po- 
tent,  cytochalasin-independent  secretagogues  under these 
conditions, whereas the same agents act as weak, cytocha- 
lasin-dependent  agonists  when tested  with neutrophils  in 
suspension. 
1.  Abbreviations  used  in  this paper:  DFP,  diisopropylfluorophosphate; 
fMLE formylated methionyHeucylphenylalanine; HSA, human serum al- 
bumin; KRPG, Krebs-Ringer phosphate buffer with glucose; TNF, tumor 
necrosis factor. 
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neutrophils  depends  on  their  expression  of/~2  integrins 
(CDll/CD18) (23, 41, 63). It is not understood how neutro- 
phils integrate signals from adhesion receptors and agonist 
receptors  before committing to  secretion.  The  following 
events all appear to be essential: a sustained fall in cAMP 
(41); spreading of the cells (41); reorganization of the actin- 
based cytoskeleton to form focal adhesions (41); and tyro- 
sine phosphorylation of  proteins associated with these adhe- 
sions (18). We have speculated (18, 41) that the reorganiza- 
tion  of the  actin-based  cytoskeleton from  a  subcortical 
meshwork into focal adhesions may remove a barrier to exo- 
cytosis and provide a  nidus for the colocalization of inte- 
grins, functionally important tyrosine phosphoproteins, and 
components of the respiratory burst oxidase (43, 66). 
It has not been clear how the behavior of neutrophils in 
such culture systems relates to more complex physiologic 
conditions. Our efforts to explore this question revealed that 
plasma and serum suppress cell spreading-dependent neu- 
trophil responses to physiologic agonists. A major compo- 
nent of serum contributing to suppression proved to be albu- 
min. Human serum albumin (HSA)  acted at an early step 
distinct from the binding of the agonists to their receptors. 
These  observations  directed  our  attention  to  molecular 
events by which one such agonist, TNF-ct, induces spreading 
of neutrophils, and mechanisms by which HSA may interfere 
with this process. 
The  ability of neutrophils to  spread  appears  to be  re- 
stricted by their expression of sialoproteins at the cell sur- 
face, perhaps because of electrostatic repulsion associated 
with the glycans' negative charge. Treatment with exogenous 
sialidase reduces the negative charge of neutrophils (10) and 
increases their adhesiveness (10, 24).  Treatment of neutro- 
phils with secretagogues is accompanied by a reduction in 
their negative charge (20).  Neutrophils activated in this way 
express a sialidase on their surface (10). A sialidase inhibitor 
blocks the decrease in the negative charge of the ceils and 
their increased adhesion to plastic (10). Activated neutro- 
phils shed the sialoprotein CD43 (sialophorin; leukosialin) 
(7, 32, 55), a process antagonized by protease inhibitors (7, 
55). Exogenous sialidase markedly potentiates the ability of 
an exogenous protease to cleave CD43  from lymphocytes 
(51). Thus, for neutrophils to spread, they may have to mobi- 
lize sialidase and proteases for a concerted attack on surface 
sialoproteins. 
In the present study, we observed that treatment with siali- 
dase markedly enhanced the ability of TNF to induce cell 
spreading and a respiratory burst in neutrophils plated on 
serum- or fibronectin-coated plastic,  and antagonized the 
ability of HSA to inhibit these responses. The predominant 
sialoprotein on the surface of neutrophils was CD43.  Treat- 
ment with TNF led to shedding of CD43, but only in neutro- 
phils adherent to a protein-coated surface. HSA but not oval- 
bumin blocked the TNF-induced loss of CD43.  Exogenous 
sialidase  and  elastase  each  caused  the  loss  of  CD43- 
associated epitopes from the cell surface, and HSA blocked 
their ability to do so. In contrast, ovalbumin did not protect 
CD43 from sialidase, and HSA did not protect a synthetic 
substrate. Thus the target of HSA appeared to be CD43 it- 
self. This interpretation was supported by the specific bind- 
ing of extracellular CD43 to HSA, and by the ability of two 
anti-CD43 mAbs to mimic HSgs inhibitory effects on neu- 
trophil function. 
These results suggest that albumin may act physiologically 
to damp massive secretory responses by neutrophils in the 
circulation and in the stages of inflammation characterized 
by formation of exudates. CD43 hinders spreading by neu- 
trophils. HSA appears to inhibit spreading-dependent neu- 
trophil functions by binding to CD43 and interfering with the 
ability of neutrophils to shed it. 
Materials and Methods 
Cell Preparation and Functional Responses 
Neutrophils were isolated from normal donors' heparinized venous blood 
on a one-step, modified Ficoll-Hypaque gradient and resuspended in ice- 
cold Krebs-Ringer phosphate buffer with glucose  (KRPG)  as described 
(41).  For measurements of H202 release and adherence, lysis of the few 
contaminating erythrocytes was avoided, since it risks activating the cells. 
For  experiments  analyzing cell-surface  sialoproteins,  erythrocytes  were 
lysed by resuspending the cell pellets in 0.2% NaCI, followed 30 s later by 
addition of an equal volume of 1.6% NaCI; the procedure was repeated if 
necessary. Polystyrene Primaria  ~ tissue culture plates (6-nun-diam wells) 
(Falcon Labware; Becton-Dickinson & Co., Oxnard, CA) were precoated 
with FBS, fibrinogen or fibronectin and washed as described (41). Plates 
containing reaction mixture consisting of 100 t~l/well KRPG with 0.44 pur- 
purogallin  U/mi HRP,  4  nmol scopoletin,  1 mM NaN3 (to inhibit my- 
eloperoxidase), and the indicated test agents were prewarmed to 37°C in 
air. Test agents were PMA (100 ng/ml), recombinant human TNF (Genen- 
tech,  Inc.,  South  San  Francisco,  CA)  at  the  indicated  concentrations, 
N-formylated  methionylleucylphenylalanine  (fMLF)  (10  -6  M),  recom- 
binant human  complement  component  C5a  (Pfizer,  Inc.,  Groton,  CT) 
(10  -8 M), or buffer alone. Respiratory burst assays were begun by adding 
1.5  x  104 cells/well. The HRP-catalyzed oxidation of scopoletin by H2(h 
was recorded at 15-rain intervals for 2 h in a plate-reading fluorometer (41). 
To test reversibility of HS/~s effects, plates were flicked empty after the 60- 
min reading, flooded with warm KRPG, flicked again, then repleted with 
100/~1  warm reac~on mixture per well. Cell spreading was monitored at 
30-rain intervals by inspection on an inverted phase-contrast microscope. 
For assays of adherence, the cell number was inereasad to 105/well.  At 
30 and 60 rain, separate plates were flicked empty and flooded with 0.9% 
saline, three times. The residual adherent cell protein was measured as de- 
scribed (41). 
Cell  spreading  was  recorded  photographically  using  ghitaraldehyde- 
fixed monolayers derived from 2  x  105 cells plates on protein-coated glass 
coverslips as detailed (41). 
Cyclic AMP was measured by radioimmunoassay in lysates of 7--9  x 
105 neutrophils per 16-mm-diam FBS-coated wells as reported (41). 
lISA Preparations 
Electrophoretically pure HSA was obtained from Armour Pharmaceuticals 
(Kankakee, IL), Calbiochem Corp.  (San Diego,  CA), and The New York 
Blood Center and protein concontration determined by the method of Lowry 
et al.  (35) using BSA as a  standard. 
To remove lipids, 30 nag HSA in 100 #1 was extracted with 50 #1 each 
of chloroform and methanol. After eantrif~tgation at 8,000 g for 4 rain, the 
organic layer was reserved and the precipitate re-extracted in the same man- 
ner. The pooled organic layers were evaporated under N2 and the residue 
resuspended by vortexing in 100/zl KRPG. A control organic phase was pre- 
pared by evaporating 100/zl each of chloroform and methanol and vortexing 
the residue with  100 tzl KRPG.  The twice-extracted precipitate from the 
aqueous layer was likewise redissolved/resuspended in 100 t~l KRPG. All 
three preparations were then compared  in a  dose-dependent manner for 
their ability to  suppress  the release of H20~  induced  by  TNF  but  not 
by PMA. 
To prepare HSA-derived peptides, 2 mmol HSA was dissolved in 5 ml 
of 200 mM Tris, 6 M guanidine HC1,  20 mM EDTA, pH 8.5,  and made 
0.3-3.0 mM in 2-mereaptoethanol. A fivefold molar excess of 2-vinylpyri- 
dine (Aldrich Chemical Co., Milwaukee, WI) was added and the solution 
incubated for 30 min at 37°C, followed by extensive dialysis against 0.9% 
saline in the cold using tubing with a  1-kD cut-off (Spectropor Industries, 
Los Angeles, CA). The dialysate was brought to 0.1 N HCI and a 50--500- 
fold molar excess of CNBr added. After 40 h at room temperature in the 
dark, the preparation was dialyzed extensively against 20 mM acetic acid, 
100  mM  NaC1,  pH  2.9.  Alternatively,  reduction  and  alkylation  were 
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50-fold molar excess of CNBr was added. After 20 h at room temperature, 
the solution was diluted with 1 vol of H20, chilled, and brought to 70-75 % 
saturation with (NH4)2SO4.  The pellet was collected by centrifugation, 
resuspended in PBS, and dialyzed against 0.9% saline. The supernate of  the 
dialysate was concentrated in polyethylene glycol 8,000 and brought to 6 M 
in urea. Reversed phase chromatography was carded out on 6-mg samples 
at room temperature on a Waters system (Waters Assoc., Milford, MA) with 
a Vydac phenyl column (25 cm x  4.6 mm internal diam, 5 mm pore size) 
(Separation Group, Hesperia, CA), eluting at  1 ml/min with 0.1%  triflu- 
oroacetic  acid  in  water  and  a  stepped gradient  ranging  from 0-100% 
acetonitrile. After the protein concentration of each fraction was measured 
by the Bradford assay (Bio Rad Labs, Hercules, CA), equal amounts of pro- 
tein were subjected to SDS-PAGE analysis and the fractions were dried in 
a  Speedvac (Savant  Instruments, Inc., Farmingdale, NY).  For assay,  the 
residues were redissolved in 5 mM glycine, 2.3 mM HCI, pH 3.0. Fractions 
with similar Coomassie blue staining patterns were pooled, diluted in the 
same glycine-HC1 buffer and added to the H202  assay in a volume of 10 
#l/well.  Controls included a  protein-free fraction eluting late  from the 
phenyl column and processed in the same way, and glycine-HC1 buffer 
alone. 
Modification and Detection of 
Cell-Surface Sialoproteins 
Where indicated, neutrophils suspended in KRPG on ice were exposed to 
50 mU/mi of C. perfringens  sialidase (Type X; Sigma Immunochemicals, 
St. Louis, MO) for 30 rain and then plated. These conditions were chosen 
after preliminary experiments tested the effect of varying the concentration 
of sialidase (0.5, 5.0, or 50 mU/ml), temperature (4  ° or 37°C), and duration 
of treatment (10, 20, 30, or 60 rain before plating the cells, with or without 
wash-out). A wide range of conditions gave similar results. 
To radiolabel cell-surface sialoproteins (19), 2  x  107 neutrophils/ml per 
sample in KRPG were treated on ice with sialidase or buffer alone, then 
made 1 mM in sodium period,ate  (Baker Chemical Co., Phillipsburg, NJ). 
5 min later, 0.2 ml of 0.1 M glycerol in KRPG was added and the cells were 
washed three times in KRPG by centrifugation in the cold. The cells were 
then rotated for 30 min at room temperature with 0.5 mCi/tube of sodium 
3H-borohydride (sp. act. 468.7 mCi/mmol) (Dupont, Wilmington, DE) and 
washed three times. The pellets were lysed in 1% Triton X-100 with 5.7 mM 
diisopropylfluorophosphate (DFP), 5 ~tg/rrd pepstatin, 5/~g/rni leupeptin, 
and 1 mM PMSF in 10 mM Tris, pH 7.4 (lysis buffer). Protein was mea- 
sured by the Bradford method in the superuatant after centrifugation at 
8,000 g for 10 min. Equal amounts of protein per lane were subjected to 
10% SDS-PAGE, followed by autoradiography and immunoblot. Radioac- 
tivity did not interfere with chemiluminescent  detection of immunoblots, for 
which the film was exposed for only 1-5 min (see below). 
For testing the effects of exposure to endogenous C. perfringens sialidase 
or purified neutrophii elastase (Calbiochem Corp.) on CD43,  107 neutro- 
phils in 1 ml KRPG per condition were suspended in FBS-precoated poly- 
propylene microfuge tubes. For sialidase treatment, neutrophils were kept 
on ice; for treatment with elastase, they were kept at 37°C. Enzyme-free 
controls showed some spontaneous shedding of CD43 at the higher temper- 
ature  (not shown). After 20  min, the cells were washed three times in 
KRPG. The pellets were lysed in 125 #1 lysis buffer and processed for im- 
munoblot as described above. 
Adherent cells were prepared by plating ~107  neutrophils in 7  ml of 
H202 reaction mixture in one 100-mm petri dish per condition tested. The 
dishes had been precoated with 3 ml each of FBS. After addition of test 
agents, the cells were incubated at 370C  in air and inspected periodically 
on an inverted phase-contrast microscope until the TNF-treated cells began 
to spread, typically at 30-60 rain. At this point, all plates were placed on 
ice and the nonadherent cells were collected. The adherent cell monolayer 
was rinsed twice with KRPG to remove HSA and the rinse was pooled with 
the nonadherent cells. The nonadherent cells were washed twice by cen- 
trifugation and resuspension in KRPG to remove HSA. After a final cen- 
trifugation, the pellets were each resuspended in the same 125-t~1 aliquot 
of lysis buffer that had been incubated for 15 min on ice with the corre- 
sponding monolayer of adherent cells. Suspended cells were prepared with 
the same amounts of cells and medium as for adherent cells, but were tum- 
bled in FBS-precoated tubes at 37"C until being washed and lysed as above. 
For immunoblot, samples were transferred electrophoretically to nitro- 
cellulose (Schleicher & Schuell, Inc., Keene, NH). The filters were blocked 
with 5 % nonfat milk (Carnation Corp., Los Angeles, CA), 0.05 % Tween-20 
in PBS, and then exposed to  1:2,000  dilution of mouse IgG1  anti-CD43 
mAb MEM59 (43) (SolarCare Technologies, Bethlehem, PA), or a 1:1,000 
dilution of mouse IgG1 anti-CD43 mAb L10 (51), a kind girl ofE. Remold- 
O'Donnell (Center for Blood Research, Boston, MA) in 2.5 % milk, 0.025 % 
Tween-20 in PBS for 2 h at room temperature. After three washes with 
0.05 % Tween-20 in PBS, the antibody-stained bands were visualized by en- 
hanced chemiluminescence according to the instructions of the manufac- 
turer (Amersham Corp., Arlington Heights, IL). 
Fluorogenic Assays  for Sialidase and Elastase 
C.  perfringens  sialidase  (0.3  mU/well)  was  incubated  with  4-methyl- 
umbelliferyl-N-acetyl-neuraminic acid (Sigma Immunochemicals) (10, 49) 
at 0.5 mM in 100 ml of 0.1 M sodium acetate buffer, pH 4.6,  in microtest 
plate wells, along with various concentrations of HSA. After 15 rain at 
37°C, samples were alkalinized with 50 #1 1 N NaOH, product solubilized 
with 50/~1 ethanol, and fluorescence recorded in a fluorometric plate reader 
(Flow Laboratories, Inc., McLean, VA). As described (6), purified neutro- 
phil elastase (0.1 t~g) was incubated at 370C with Ala-Ala-Pro-Val-7-amido- 
a-methyl coumarin (0.25 mM) (Sigma Immunochemicals) in 100 t~l of 150 
mM NaCI with 20 mM Tris, pH 8.0 in the presence of various concentra- 
tions of HSA and fluorescence recorded at 5-rain intervals from 5-30 rain. 
Both reactions were evaluated in comparison to a standard curve prepared 
with 4-methyl-umbelliferone (Sigma Immunochemicals). A separate stan- 
dard curve was constructed for each concentration of HSA. 
Affinity PUrification of CD43 on HSA-Sepharose 
Cyanogen bromide-activated Sepharose 4B (Pharmacia Fine Chemicals, 
Piscataway, N J) was coupled at a ratio of 333 mg gel to 7.5 nag HSA, ovalbu- 
min or glycylglycine and blocked according to the manufacturer's instruc- 
tions. Soluble, extracellular domains of CIM3 were collected by treating 
2  x  l0  s neutrophils in 1 ml KRPG with 5 mM DFP for 10 rain on ice and 
then bringing the cells to 42 ml in H202 reaction mixture containing 2 mM 
leupeptin, 1 #g/m1 soybean trypsin inhibitor, 0.5 ~g/ml aprotinin, and 5 mM 
iodoacetamide, distributing them in six tubes and tumbling them with 100 
ng/rrd FMA for 30 rain at 37°C. After centrifugation, one third of  the pooled 
supematants was passed over each of the three columns at room tempera- 
ture. The effluent of each column was recycled on the same column twice. 
Total dwell time on the columns was 2-3 h. The effluent of the third pass 
was reserved and pooled with the first 2 ml eluting during a wash with 20 
ml of KRPG. These pools were concentrated in Centficon tubes with a  10 
kD cut-off (Amieon Division of W. R.  Grace,  Danvers, MA).  Material 
bound to the washed columns was then eluted with 1 M NaC! in KRPG in 
20 fractions of 0.5 mi each. Those fractions containing protein were con- 
centrated by filtration as above.  All concentrated samples at equivalent 
volumes on a per-cell basis were then subjected to SDS-PAGE and immuno- 
blot with anti-CIM3 mAbs. 
Other Procedures and Reagents 
Peptides were sequenced at The Rockefeller University Protein Sequencing 
Facility (New York) by Edman degradation. The limnius amebocyte lysate 
assay kit for bacterial lipopolysaccharide was from Whittaker Bioiogicals, 
Walkersville, MD.  Mouse IgG1  anti-human neutrophil Fc receptor m_Ab 
3G8 (16) was a kind gift of J.  Unkeless (Mt. Sinai Medical Center, New 
York). Mouse ascites containing IgG1 anti-gelsolin mAb and other reagents 
whose sources have not been specified above or in ref. 41 were from Sigma 
Immunochemicals. 
Results 
HSA Selectively and Reversibly Suppresses the 
Respiratory Burst of  Adherent Neutrophils 
Neutrophils were plated on FBS-coated plastic in KRPG and 
observed over a 2-h period. No H202 was released unless 
the cells were exposed to PMA, TNE or fMLF. All three 
agonists provoked a massive respiratory burst, although the 
response to the two physiologic agonists began after a long 
delay (Figure  1 A), consistent with previous observations 
(39, 41, 42). When the medium was supplemented with 1.5 
mg/ml HSA, the response to PMA was augmented: instead 
of approaching a plateau by 75 min, it remained nearly linear 
through 120 min. This excluded that HSA was toxic to the 
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Figure 1.  HSA suppresses the neutrophil respiratory burst selec- 
tively and reversibly, but only if added before its onset. Neutrophils 
were exposed  to  PMA  (100 ng/ml)  (e),  TNF  (10  ng/ml)  (A), 
fMLF (10  -~ M) (4,) or buffer alone (m), and were additionally in- 
cubated either with buffer alone or HSA (1,500 #g/ml) for the first 
60 rain of the experiment. At that point (vertical arrows), all plates 
were flicked empty, rinsed, repleted with fresh reaction mixture and 
exposed to HSA or not for the remaining 60 min, as indicated above 
each panel. PMA, TNE and fMLF were not added back after the 
plates were washed. Data are means :t: SEM of triplicates. In this 
and subsequent figures, some of the error bars fall within the sym- 
bols denoting the means. 
neutrophils or interfered with the assay system. In contrast, 
HSA abolished the release of H202 in response to TNF or 
fMLF (Fig. 1 B). The suppressive effect of HSA was revers- 
ible, because when the medium was changed at 60 min and 
replaced with HSA-free medium, H202 release in response 
to TNF began after a typical lag (Fig.  1 C). TNF was only 
added to the medium in the first stage of the assay. When the 
HSA was removed, TNF was not replaced, so that the cells 
were presumably responding to TNF that had bound earlier 
in the presence of HSA. This suggested that HSA did not in- 
terfere with the binding of TNF to its cell surface receptors. 
Finally, HSA only blocked the TNF- and fMLF-induced re- 
spiratory burst if added before its onset. Thus, HSA had no 
effect if it was added 60 min after TNF or fMLF (Fig.  1 D). 
This indicated that the critical action of HSA was confined 
to an early event in the response to neutrophils to TNF and 
fMLE  Results  were  similar  when  TNF  and  fMLF  were 
replaced by an agonistic mAb against the 55-kD TNF recep- 
tor  (HT-9,  10  #g/ml)  (5)  or by  10  -8  M  recombinant C5a 
(not shown).  That HSA inhibited H202 release in response 
to four different agonists was further evidence that HSA did 
not act by interfering with their binding. 
Suppression of the TNF-induced respiratory burst was de- 
pendent on the concentration of HSA added to the medium. 
With  TNF  at  1 ng/ml,  neutrophils  plated on FBS-coated 
plastic were half-maximally suppressed by 46/zg/ml HSA 
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Figure 2. Concentration dependence of HSA-mediated suppression 
of the TNF-induced respiratory  burst, and partial reversal of sup- 
pression  by increasing concentrations  of TNF. Neutrophils  were 
plated in wells precoated with fibronectin (left panel) or FBS (right 
panel).  At a fixed concentration of TNF (1 ng/ml) (A), HSA sup- 
pressed H202 release in a dose-dependent manner, as indicated by 
the scale above each panel (#g/ml). At a fixed concentration of HSA 
(1,500 #g/ml) (e), suppression was partly overcome by increasing 
concentrations of TNF, as indicated by the scale below each panel 
(ng/ml).  Data are means  +  SEM of triplicates. 
(Fig. 2). The IC50 ranged up to 180 #g/ml HSA in other ex- 
periments. Suppression by HSA did not depend on the use 
of FBS to coat the plastic, but was also evident with fibronec- 
tin  (IC50, 105  #g/ml  HSA)  (Fig.  2)  or  fibronectin  (not 
shown)  as  coatings.  At a  concentration  of HSA threefold 
greater than that required to produce maximal suppression 
of the response to 1 ng/ml TNF, increasing the TNF concen- 
tration  to  100  ng/ml  restored  H202  release  to  53%  (on 
fibronectin) or 72 % (on FBS) of the level seen without HSA 
(Fig.  2). 
Table I  summarizes results of 22 experiments.  H202  re- 
lease in response to TNF was always suppressed, but never 
abolished,  even when HSA was added  at 5  mg/ml.  At  15 
mg/ml, HSA interfered with the assay used to detect 14202 
(not shown) (56). In contrast, ovalbumin (Table I), lactofer- 
rin and transferrin (not shown)  neither suppressed the re- 
sponse to TNF nor augmented the response to PMA.  Thus 
the actions of HSA in this system were not simply a conse- 
quence of adding protein. 
HSA Reversibly Suppresses  TNF-induced Spreading 
Because HSA suppressed a  functional response of neutro- 
phils at an early step, and because spreading is an early event 
essential for the functional response tested, we examined the 
effect of HSA on TNF-induced spreading of neutrophils. The 
design of these experiments was patterned on that in Fig.  1. 
Within  30 min of exposure to TNE neutrophils were well 
spread in an irregular and often crescentic shape (Fig. 3 a). 
Spreading proceeded to a disk-like shape by 60 min, .even 
though the medium was changed at 30 min and TNF was not 
replaced (Fig. 3 c). The continuous presence of HSA from 
time 0 blocked spreading at both 30 min (Fig.  3 b) and 60 
min (Fig. 3 d), although the neutrophils remained adherent. 
In contrast,  HSA had no effect on spreading if its addition 
was delayed until after spreading had already commenced 
(HSA added from 30-60 rain;  Fig.  3 e).  Conversely, cells 
prevented from spreading for 30 min in the presence of HSA 
began to spread at the normal rate when HSA was removed, 
even though fluid-phase TNF had been removed along with 
the HSA and was not added back (Fig.  3 f). 
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Agent  Concentration  Measure  TNA  TNF  PMA 
#g/ml  1 ng/ml  10 ng/ml  100 ng/ml 
HSA  0  nmol*  2.20  +  0.18(15)  2.52  +  0.16(13)  2.96  +  0.16(22) 
10-15  %  of control+  98  5:  6(8)  ND  106  5:  0(3) 
30-50  "  79  5:  9(9)  85  :t: 4(3)  102  5:  4(5) 
100-150  "  38  5:  8(11)  46  5:  11(5)  94  5:  2(5) 
300-500  "  12  +  2(12)  27  5:  8(7)  102  5:  4(9) 
1,000-1,500  "  15  5:  7(5)  22  -t- 5(9)  126  5:  3(18) 
3,000-5,000  "  15  5:  4(2)  15  5:  3(3)  133  5:  6(7) 
Ovalbumin  1,500  "  103  5:  5(3)  ND  92  5:  3(4) 
* Nmol H202 released/1.5  x  104 neutrophils 60-120 rain after plating the cells in wells precoated with FBS, fibronectin or fibrinogen. The time-point selected 
for each experiment was that at which the TNF response reached ,',,90% of maximum  (mode, 75 rain). Means 5- SEM, where each datum is the mean of an experi- 
ment performed in triplicam, for the number of experiments in parentheses. Spontaneous release (without TNF or PMA) averaged 0.14 +  0.03 (n =  23 experi- 
ments) and was unaffected by HSA or ovalbumin. 
Results for the HSA- or OVA-treated sets expressed as a percent of the corresponding HSA-, OVA-free set in the same experiment. Means -I- SEM for the 
number of experiments in parentheses. 
Results with PMA as agonist were strikingly different than 
with TNE Neutrophils treated with PMA proceeded directly 
to disk-like spreading, as illustrated in references 18 and 41. 
HSA hastened rather than inhibited PMA-induced spreading 
(not shown). 
HSA Does Not Affect TNF-induced Cell Attachment 
Morphologic observations like those recorded in Fig. 3 sug- 
gested that the number of neutrophils adherent to FBS-, 
fibrinogen-,  or  fibronectin-coated  plastic  or  glass  was 
unaffected by HSA, even though the cells were prevented 
from spreading. This was quantified by subjecting monolay- 
ers of neutrophils to vigorous washing and measuring the re- 
sidual adherent cell protein. By this test, adherence of neu- 
trophils increased more than  10-fold in response to TNF, 
whether or  not HSA  was  present  (Table  II).  This  result 
provided a third piece of evidence that HSA did not act by 
interfering with the binding of TNF to its receptors. 
lISA Blocks the TNF-induced Fall in cAMP 
Spreading of TNF-treated neutrophils depends on a fall of 
cAMP that persists at least until spreading starts (41). HSA 
not only blocked the ability of TNF to induce cell spreading, 
but also prevented the associated fall in cAMP, measured 45 
min after plating the cells (Table III). 
Suppressive Activity Is Intrinsic to HSA and Some of 
its Proteolytic Fragments 
Since HSA can act as a carder for other molecules (37),  it 
was important to determine whether the suppressive activity 
on spreading-related responses of neutrophils was intrinsic 
to HSA. The experiments summarized in Table I were car- 
ried out with HSA from three different suppliers.  All lots 
were free of bacterial lipopolysaccharide by a limulus ame- 
bocyte lysate assay sensitive to 10-20 pg/ml. All three prepa- 
rations were pure by the criterion that only a single band was 
visible by Coomassie blue staining after running 10 #g HSA 
on SDS-PAGE (not shown). As monitored by suppression of 
H202 release in response to TNF, chloroform-methanol ex- 
traction of HSA distributed all bioactivity to the protein 
phase and none to the lipid phase. Nonspecific toxicity was 
excluded, because  H202  release in response to PMA was 
unaffected (not shown). 
Finally, HSA was digested with CNBr with or without 
prior reduction and alkylation, and chromatographed by a 
variety of methods. We only isolated one CNBr fragment of 
HSA in pure form. This species, which migrated at 20.0 kD 
on SDS-PAGE,  was identified by NH2-terminal sequencing 
(XTAFHDNEET) as arising from the CNBr cleavage site at 
Met  lu and beginning with the adjacent Cyst25; it presum- 
ably continued to the next Met, which follows amino acid 
298 (20.0 kD) (14). Peptide 124-298,  which is the largest 
CNBr fragment of  liSA, accounting for 30% of  its mass, was 
inactive  in  the  H202 bioassay  (not  shown).  However, 
reversed phase HPLC on a phenyl column (Fig. 4,4)  did 
yield a pool of fractions highly active at suppressing HeO~ 
release induced by TNF (Fig. 4 B) and not by PMA (Fig. 
4 C). This pool was enriched in polypeptides migrating at 
47, 37, 32, 22,  12, and 10 kD, along with smaller species 
migrating at the dye front (not shown) (the three larger spe- 
cies are incomplete digestion products). The active polypep- 
tide pool was eightfold more potent on a weight basis than 
HSA itself (Fig. 4 B), perhaps reflecting the increased molar 
concentration of the active peptide(s) relative to the parent 
molecule. Although these results fell short of  identifying  bio- 
active region(s) of HSA, they suggested that the suppressive 
activity of HSA was intrinsic to certain portions of the mole- 
cule and not others. 
Sialidase Enhances Cell Spreading and the 
Respiratory Burst Induced by TNF and Prevents 
Inhibition by HSA 
We turned next to the mechanism of TNF-induced spreading 
of neutrophils, in order to see how HSA might interfere with 
it. We began by testing the possibility that spreading is regu- 
lated by cell-surface sialoproteins. 
When neutrophils were plated on FBS-coated dishes after 
pretreatment with C. perfringens  sialidase, they remained 
nonadherent, spherical, and refractile by phase-contrast mi- 
croscopy (not shown) and released no H202 over a 120-rain 
period of observation (Fig. 5 A). Moreover, sialidase had no 
effect on the rapid cell spreading and 1-1202 release induced 
by PMA (Fig. 5 A). In contrast, pretreatment with sialidase 
markedly enhanced responses to TNE In the experiment il- 
Nathan et al. Albumin, Cell Spreading, and Shedding of CD43  247 Figure  3.  HSA reversibly inhibits TNF-induced cell spreading, but only if added before its onset. TNF (10 ng/ml) was added at time 0 
to neutrophils on FBS-coated glass coverslips. At 30 min, coverslips were either fixed or transferred to fresh medium without TNE  (a) 
No HSA added; cells fixed at 30 min. The cell spreading was TNF-induced, since without TNF, the neutrophils remained phase-bright 
and spherical, as illustrated in Fig. 6/of  ref.  18. (b) HSA (1,500/~g/ml) added at time 0; cells fixed at 30 min. (c) No HSA; cells fixed 
at 60 min. (d) HSA added at time 0  and again at 30 min; cells fixed at 60 min. (e) HSA first added at 30 min; cells fixed at 60 min. 
(f) HSA added at time 0,  but not again at 30 min; cells fixed at 60 min. 
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to FBS-coated Plates* 
Stimulus 
HSA  None  TNF$  PMA§ 
~tg/ml  tzg adherent cell protein~well 
0  0.9 5- 0.2(4)11  10.4 +  0.6(4)  10.6 +  0.8(4) 
500  0.3  5- 0.2(3)  9.9 5: 0.3(3)  10.8 +  0.3(3) 
1,500  0.8 +  0.0(2)  8.3  +  0.2(2)  10.2 5- 0.2(2) 
* Adherence was measured 60 min after plating 10  ~ neutrophils per FBS- 
coated well. 
10 ng/ml. 
§ 100 ng/ml. 
II Means 5: SEM for mean results from (n) experiments, each in triplicate. 
Table II1. HSA Blocks the  TNF-induced Fall in cAMP in 
Adherent Neutrophils* 
Stimulus 
HSA  None  TNF$ 
ttg/ml  Percent of control 
0  100(3)§  66.4  +  2.6(3) 
1,500  91.7  +  3.9(4)  96.4  +  10.6(4) 
* cAMP was measured 45 rain after plating neutrophils in FBS-coated  wells. 
:t:  10 or 100 ng/ml. 
§ Means + SEM for the mean results from (n) experiments, each in triplicate. 
Values for the controls (no HSA, no TNF) averaged 0.41 + 0.06 pmol/106 
neutrophils. 
lustrated  in Fig.  5  B,  spreading  (not shown) and H202 re- 
lease to an effective concentration of TNF (1 ng/ml) began 
23 min earlier than without sialidase.  Moreover, with siali- 
dase, TNF was able to induce cell spreading and a respira- 
tory burst at 0.1 ng/ml, a concentration ineffective on neutro- 
phils not exposed to sialidase (Fig. 5 B). Thus, sialidase and 
TNF acted synergistically. 
HSA-mediated suppression of the respiratory burst in re- 
sponse  to  TNF  was  largely  forestalled  in  neutrophils 
pretreated with sialidase (Fig. 5  C).  Likewise, sialidase re- 
stored TNF-induced cell spreading in the presence of HSA 
(not shown). 
These  findings  suggested  that  cell-surface  sialoproteins 
might normally counteract TNF-induced spreading and the 
respiratory burst, and might also be a target for the inhibi- 
tory actions of HSA on these two processes. 
CD43 Is the Predominant Cell Surface Sialoprotein 
of Neutrophils 
CD43 is a  myeloid-specific mucin that represents  the pre- 
dominant  cell  surface  sialoprotein  on  lymphocytes  (50). 
CD43 is expressed by neutrophils (7,  8,  17, 52, 55), but the 
proportion  of neutrophil  cell  surface  sialoproteins  repre- 
sented by CD43 has apparently not been clearly established. 
Cell surface sialic acids can be specifically labeled by briefly 
exposing cells to low concentrations of sodium periodate at 
O°C and reducing the resulting aldehydes with tritiated boro- 
hydride (19).  Application of this procedure to neutrophils 
A 
02- 
0.1-- 
35% 
100% 
Ac~on~le.%  Jl.i~I II  -(--42% 
0  20  40  60  80  100  120 
I~nu~14 
I 
L 
140 
B 
2.5 
-=E zo: 
1.5. 
~  LO.  c 
0.5. 
00. 
C 
30 
25: 
2,0 
~c  15 
1,0 
0.5 
0.0 
-l--  HSA 
--e--  CNBr d~gested 
-e~  Fractions 75-84 
Fr~  136 
Figure 4.  A  subset  of HSA- 
derived  CNBr  fragments  is 
enriched in suppressive  activ- 
ity for the TNF-induced respi- 
ratory  burst.  (A)  Reversed 
phase  HPLC  chromatogram 
following injection of 6 mg of 
HSA-derived  CNBr  frag- 
ments.  The  phenyl  column 
was eluted  at  1 ml/min with 
0.1%  trifluoroacetic  acid  in 
water and the  indicated  gra- 
diem  of  acetonitrile.  All 
protein-containing  fractions 
were subjected  to SDS-PAGE 
and  those  with  similar 
Coomassie blue staining  pat- 
terns  were pooled.  Maximal 
bioactivity was  recovered  in 
the  pool  of fractions  75-84 
(eluting  with  42-58%  ace- 
tonitrile;  double-headed  ar- 
row).  (B)  Potency  of  pool 
75-84 in suppression of neu- 
trophil H~(h  release  induced 
by TNF (1 ng/ml).  As a con- 
trol  for  nonspecific  effects, 
fraction  135, which  lacked 
measurable  protein,  was 
processed and diluted  in the 
same way as the highest  con- 
centration of pool 75-84.  In 
addition, glycine-HCl buffer alone had no effect on neutrophil  morphology or respiratory burst (not shown). Means +  SEM for triplicates. 
(C) Lack of effect of pool 75-84 on neutrophil  H202 release  induced by PMA (100 ng/ml).  Means  +  SEM for triplicates. 
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Figure 5. Effect of sialidase on 
the  neutrophil  respiratory 
burst.  Neutrophils  were  ex- 
posed to C. perfringens siali- 
dase (50 mU/ml for 30 rain at 
0°C) and then dispensed at 1.5 
x  104  cells/ml  to  prewarmed, 
FBS-coated plates  with (A) 0 
or 100  ng/ml  of  PMA;  (B)  0.I 
or I ng/ml of  TNF; or (C) 1 
ng/ml  of  TNF with  or  without 
I00  #g/ml  HSA.  H202  re- 
lease  was monitored over the 
next 2 h. Data are means  + 
SEM  of  triplicates. 
revealed a band at ~130-kD (17a).  This was interpreted as 
leukosialin, yet it migrated faster than the material immuno- 
precipitated by a rabbit anti-leukosialin ab (17a). To resolve 
this issue, we surface-labeled PMN sialic acids as in the ear- 
lier  studies  (17a,  19),  subjected the cell lysates to  SDS- 
PAGE, compared the autoradiograms to immunoblots with 
anti-CD43 mAb, and tested the effect of pretreating the cells 
with sialidase (Fig. 6). The autoradiograms revealed a dou- 
blet at 125-137 kI), a relative molecular mass characteristic 
of CIM3 in neutrophils (50). When periodate was omitted, 
no radiolabel was detected (not shown).  Treatment of the 
neutrophils with 5  mU/ml  C  perfringens sialidase for 20 
rain at 0°C before exposure to periodate reduced the inten- 
sity of radiolabeling and elevated the apparent molecular 
mass of the resulting species to 159 kD. With 10-fold more 
sialidase, a single radiolabeled species was faintly detectable 
at 175 kD (Fig. 6). The paradoxical decrease in mobility in 
SDS-PAGE  after  desialylation  is  characteristic  of CD43 
(50).  Bands migrating at the same positions as on the au- 
toradiograms, and no other bands, were seen when the same 
samples were immunoblotted with MEM59, a mAb specific 
for a sialyl-dependent epitope of CD43 (Fig. 6) (64). Thus, 
CD43 is the predominant sialoprotein on the surface of hu- 
man neutrophils. 
Figure 6.  Characterization of 
sialoproteins on human PMN. 
Neutrophils were treated  for 
20 min at 0°C with 0, 5, or 50 
mU/ml sialidase, followed by 
brief  oxidation  with  NaIO4 
and  reduction  with  3H-bo- 
rohydride.  The  washed cell 
pellets were lysed and 100 #g 
cell protein/lane subjected to 
SDS-PAGE, followed  by auto- 
radiography  or  immunoblot 
with mAb MEM59, which de- 
tects  a  sialyl-dependent epi- 
tope of CD43. The migration 
of molecular mass markers is 
indicated. 
HSA Partially Blocks Shedding of CD43 by 
TNF-Stimulated PMN 
Since HSA and sialidase antagonized each other's effects on 
TNF-induced neutrophil responses, and CD43 was the pre- 
dominant target of sialidase on neutrophils, we asked if HSA 
could block the  shedding of CD43  from activated PMN. 
First, we confirmed that TNF (7, 55) and PMA (7, 32, 55) 
cause neutrophils to shed CD43, as monitored with L10 (Fig. 
7), a mAb specific for a sialyl-independent epitope of CIM3 
contained  within  its  78  amino  acid  NH2  terminus  (51). 
While both suspended neutrophils and neutrophils adherent 
to FBS-coated plastic shed CD43 in response to PMA, only 
adherent cells  shed  CIM3  in  response to  TNF  (Fig.  7). 
These findings match the ability of PMA to stimulate a respi- 
ratory burst of similar magnitude in suspended and adherent 
PMN, while TNF only induces a respiratory burst in adher- 
ent cells (39). 
The  ,,o50%  reduction in CD43  in  adherent neutrophils 
stimulated with TNF was blocked completely by HSA, but 
not by a  control protein, ovalbumin (Fig.  7).  In contrast, 
HSA had no effect on the virtually complete shedding of 
CD43 induced by PMA (not shown). 
Figure  7.  TNF-  and  PMA- 
induced  shedding of  CIM3 
from adherent  or  suspended 
neutrophils:  effects of  HSA 
and  ovalbumin. Neutrophils 
(2  ×  104/sample in 7.0 ml at 
37°C) were tumbled in FBS- 
precoated tubes or allowed to 
adhere to FBS precoated Petri 
dishes for 60 min in the pres- 
ence or absence of TNF (100 
ng/ml),  PMA  (100 ng/ml), 
HSA (100 #g/ml), and/or oval- 
bumin  (OVA) (100 ~g/ml). 
Ceils were  collected as de- 
scribed  in  Materials  and 
Methods,  the  washed pellets 
lysed, and 50 #g of cell protein/lane subjected to SDS-PAGE, fol- 
lowed by immunoblot with anti-CD43 mAb LI0. The migration of 
molecular mass markers is indicated. 
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Figure 9. Effect of HSA on the hydrolysis of synthetic substrates  by 
sialidase  and elastase.  C. perfringens sialidase  was incubated with 
4-methyl-umbeUiferyl-N-acetyl-neuraminic  acid and the concen- 
trations  of HSA  (mg/ml)  indicated  on  the  lower  abscissa  (i). 
Purified  neutrophil  elastase was incubated with Ala-Ala-Pro-Val-7- 
amido-ct-methyl-coumarin and the concentrations of HSA (mg/ml) 
indicated  on the upper abscissa (e). 
Figure 8.  HSA  blocks  the  actions  of exogenous  sialidase  and 
elastase on neutrophil  CD43.  Neutrophils  at  1.5  x  107 cells/ml 
were suspended for 10 min at 0 ° or 37°C with the indicated concen- 
trations of HSA or ovalbumin  (OVA), and then treated for 20 min 
further  with  5  mU/ml  sialidase  (0°C)  or  20  #g/ml  neutrophil 
elastase (37°C). The washed cell pellets  were lysed and 50 #g of 
cell protein/lane subjected to SDS-PAGE, followed by immunoblot 
with two anti-CD43  mAbs: (upper panel)  MEM59,  detecting  a 
sialyl-dependent epitope, and (lower  panel) LI0, detecting a sialyl- 
independent epitope. The migration of molecular mass markers is 
indicated. 
HSA Blocks the Actions of Exogenous Sialidase and 
Elastase on CD43 
The  ability  of HSA to block  shedding  of CD43  by  TNF- 
activated neutrophils might reflect protection of CD43 from 
endogenous sialidase and proteases.  To test the plausibility 
of  this hypothesis, we asked if liSA could protect CD43 from 
attack by exogenous enzymes. 
In fact, the action of C. perfringens sialidase on neutrophil 
CD43 was completely blocked by HSA, but not by ovalbu- 
min (Fig. 8). We reasoned that HSA could inhibit the action 
of sialidase  on CIM3 either by binding to sialidase,  or by 
binding to CIM3. To test the former possibility,  C. perfrin- 
gens  sialidase  was titrated  against  a  synthetic  fluorogenic 
substrate. Under reaction conditions linear with time and en- 
zyme concentration, up to 10 mg/ml HSA inhibited hydroly- 
sis of the sialidase substrate by no more than 12% (Fig. 9). 
CD43 is generally protease-resistant  (50,  51).  However, 
pancreatic elastase can cleave CIM3 from human lympho- 
cytes in the presence of sialidase (51). Fig. 8 shows that neu- 
trophil  elastase  can cleave CD43  from human neutrophils 
even without sialidase. When HSA was included in the reac- 
tion, cleavage of  CD43 was inhibited. In contrast to the situa- 
tion with sialidase,  this was a nonspecific effect of HSA, in 
that high concentrations were required,  ovalbumin had the 
same effect (Fig.  8), and as little as 3 mg/ml HSA inhibited 
by 48 % the hydrolysis of a fluorogenic substrate by elastase 
(Fig.  9). 
Thus,  HSA blocked the action of elastase on CD43 by a 
mechanism  that  probably  involved  binding  of  HSA  to 
elastase. In contrast, protection of CD43 from sialidase ap- 
Figure 10.  Affinity  chroma- 
tography of shed extracel!ular 
domains  of CD43  on  HSA- 
Sepharose.  Neutrophils  were 
exposed to PMA (100 ng/ml) 
in the presence of protease in- 
hibitors for 30 min at 37°C as 
described  in  Materials  and 
Methods.  One third of the su- 
pernatant  was  passed  three 
times  each over a  column of 
CNBr-activated  Sepharose  to 
which had been coupled either 
(A) HSA, (B) ovalbumin,  or (C) glycylglycine.  The columns were 
washed  extensively  with KRPG and then eluted  with  1 M NaCI. 
The eluates were concentrated on a membrane with a nominal 10- 
kD cut-off. Volumes deriving from the number of untreated  neutro- 
phils in lane P (intact PMN) (lane P contains 150/~g protein)  were 
subjected to SDS-PAGE and immunoblotted with either of  two anti- 
CD43  mAbs: (left panel) MEM59,  detecting  a  sialyl-dependent 
epitope; (right panel) LI0, detecting  a sialyl-independent  epitope. 
The migration of molecular mass markers is indicated. 
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Figure  11.  Inhibition  of 
the  TNF-induced  respiratory 
burst  by  two  anti-CD43 
mAbs.  1.5  ×  104 neutrophils 
were plated per well in FBS- 
precoated  microtest  plates 
containing the indicated con- 
centrations  of  anti-CIM3 
or  isotype-matched  control 
mAbs. The cells were stimu- 
lated with TNF (100 ng/ml), 
PMA (100 ng/ml),  or KRPG 
alone, and H202 release mea- 
sured over the next 2 h by the 
fluorescent  scopoletin  assay. 
(A)  MEM59  (open symbols) 
recognizes a sialyl-dependent 
epitope on CD43. The control 
mAb  3G8  (solid symbols) 
recognizes Fc receptor IN, an 
abundant  epitope  on neutro- 
phils (16). (B) L10 (open sym- 
bols)  recognizes  a  sialyl- 
independent  epitope  on 
CD43. The control mAb aGA 
(closed symbols) recognizes 
gelsolin and is not expected to 
bind  specifically  to  neutro- 
phils. Data are means + SE of 
triplicates. 
peared to involve a  specific interaction between HSA and 
CD43 itself. 
The ExtraceUular Portion of CD43 Binds Specifically 
to HSA 
The  foregoing  findings  suggested  that  HSA  may bind  to 
CD43.  Since HSA may bind to several different molecules 
on cell surfaces (21, 60) and this hypothesis does not require 
that CIM3 be the major HSA binding site, we did not test 
the binding of HSA to cells, but instead tested the binding 
of CIM3 to HSA. Since binding of  the cytoplasmic and trans- 
membrane domains of CD43 to HSA would lack physiologic 
relevance, and since detergents might interfere with binding, 
we avoided cell lysates,  and instead used the extracellular 
portion of CD43. As a source, we suspended neutrophils in 
KRPG and stimulated them with PMA. We had to treat the 
cells with protease inhibitors to avoid degradation of shed 
CD43, even though this markedly decreased the amount of 
CD43 released (Nathan, C., and W. W. Jin, unpublished ob- 
servations). The supernatant was passed over a column of 
HSA-Sepharose. The column was washed extensively with 
KRPG.  Bound material was eluted  with  salt.  As detected 
with  mAbs  MEM59  and  L10,  the  eluate  contained  im- 
munoreactive CIM3,  but only from the column  to which 
HSA was coupled, and not from columns to which ovalbu- 
rain or glycylglycine were coupled (Fig.  10).  The fragment 
of CD43 recovered in this manner migrated on SDS-PAGE 
much  like  holo-CD43.  This  matches  observations  with 
CD43  immunoprecipitated  from  the  medium  of  PMA- 
treated neutrophils (32, 55). Thus, there is a specific interac- 
tion between HSA and the extracellular portion of CD43 in 
a medium whose ionic composition and pH reflect those of 
extracellular fluid. 
Anti-CD43 mAbs Mimic the Inhibitory Action of  liSA 
on TNF-stimulated PMN 
If HSA inhibited TNF-induced cell spreading and the respi- 
ratory burst by binding to CD43, then other CD43-binding 
proteins might have the same effect. Indeed, two different 
anti-CIM3 mAbs blocked the respiratory burst induced by 
TNF but not by PMA (Fig. 11). The mAbs were potent inhib- 
itors (ICs0 =  3 #g/ml for MEM59 IgG1 and 1:1,600 for L10 
ascites).  Likewise,  both mAbs blocked cell spreading in- 
duced by TNF, but not by PMA (not shown). Two isotype- 
matched control mAbs,  one of which  was specific for an 
abundant epitope on neutrophils (16),  were ineffective. 
Discussion 
Three sets of new findings emerge from these studies. 
I. Selective Inhibition of  Neutrophil Spreading by HSA 
First, HSA can dissociate cell attachment from cell spread- 
ing. Thus, HSA did not interfere with agonist-stimulated ad- 
herence of neutrophils to protein-coated surfaces, but acted 
as a selective, reversible, nontoxic regulator of cell spread- 
ing induced by TNE C5a or fMLE and as an inhibitor of 
at  least  two  of the  metabolic  responses  that  depend  on 
spreading, the fall in cAMP and the respiratory burst. From 
this perspective, HSA can be classed with a structurally di- 
verse group of secreted glycoproteins, such as osteonectin, 
tenascin and thrombospondin, that can support the attach- 
ment yet can antagonize the spreading of various cells (58). 
Despite the widespread use of HSA or BSA in studies of 
neutrophil  function,  we know of no studies analyzing the 
effects of serum albumin on the metabolic and morphologic 
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proteins and stimulated with physiologic agonlsts. Nearly 30 
years ago, Keller reported that HSA improved neutrophil 
function in chemotaxis chambers (25). He and other investi- 
gators went on to characterize HSA as a positive chemoki- 
netic factor for neutrophils, that is, one which facilitates the 
cells' migration up a concentration gradient of another sub- 
stance (26-28, 62, 67). One legacy of these reports is a view 
of albumin as a stimulus or tonic for neutrophils. 
The present results suggest a different interpretation of al- 
bumin's chemokinetic effect: albumin inhibits extensive cell 
spreading, which compromises migration, while sustaining 
cell attachment, which facilitates it. This view is consistent 
with observations that albumin blunted the spreading of neu- 
trophils on the polycarbonate membranes used in chemo- 
taxis chambers (27, 28). The ability of liSA to dissociate cell 
attachment from cell spreading may make it an important 
physiologic regulator of motility. 
Given the high concentration of albumin in human plasma 
(the middle of the normal range is 45 mg/ml), the question 
arises whether there can be any physiologic counterpart to 
the  adhesion-dependent  respiratory  burst  of  neutrophils 
stimulated in vitro with soluble, physiologic agonists. In this 
context, it should be  noted that suppression of the TNF- 
induced respiratory burst by HSA could be partially over- 
ridden by increasing the concentration of the agonist. Even 
at moderate TNF concentrations, suppression at the highest 
concentration of HSA that could be tested reached a plateau 
at  85%.  This still left TNF-treated,  adherent neutrophils 
releasing almost an order of magnitude more H202 than has 
typically been observed when neutrophils have been treated 
with soluble, physiologic agonlsts in suspension in the pres- 
ence of cytochalasins (reviewed in ref.  39).  Moreover, in 
early phases of inflammation, neutrophils can enter tissues 
before plasma proteins accumulate. 
Thus, the impact of HSA on neutrophils is likely to be 
biphasic during the evolution of an inflammatory response. 
The asymmetric distribution of HSA at the outset (high intra- 
vascularly, low extravascularly) may favor egress of neu- 
trophils  from vessels and their retention in extravascular 
tissues, where they may be relatively free to spread, degran- 
ulate, and undergo a respiratory burst. Leveling of the trans- 
vascular gradient of HSA in later stages of  inflammation may 
have the opposite effects. 
On a weight basis, the potency of HSA (IC50 for H202 re- 
lease, 46-180 #g/ml) and a  subset of its CNBr fragments 
(IC5o, 18 #g/ml) was comparable with or greater than that 
of several peptides derived from extracellular matrix pro- 
teins that have been shown to antagonize cell spreading or 
adhesion in vitro. For example, 1 mg/mi of the fibrinogen- 
derived peptide GPRP decreased by ,x,50 % the adherence of 
TNF-treated neutrophils to fibrinogen-coated surfaces (34). 
Similarly, spreading of BHK cells on a surface coated with 
a  fragment of fibronectin was  decreased by 50%  by  1.1 
mg/ml of GRGDS (1). Since these tetra- or pentapeptides 
(479 and 562 daltons, respectively) are far smaller than HSA 
(66.6 kD) or even the smallest of its CNBr fragments (3.4 
kD), the potency of HSA and its bioactive fragments on a 
molar basis seems relatively high. 
Inhibition  of  the  TNF-triggered  respiratory  burst  by 
plasma or serum could be accounted for quantitatively by 
their content of albumin (Nathan, C., unpublished observa- 
tions). On the other hand, HSA is not the only plasma pro- 
tein that can  suppress  TNF-induced spreading on matrix 
protein-coated surfaces and the associated respiratory burst. 
Fluid-phase fibronectin and fibrinogen can also do so (Na- 
than, C., unpublished observations), perhaps by binding to 
integrins and preventing them from clustering in focal adhe- 
sions. However, mimicry of soluble extracellular matrix pro- 
teins is unlikely to account for the mechanism of action of 
HSA  as  an  antagonist of cell  spreading.  Although HSA 
shares  16  regions  of primary  sequence  homology  with 
fibronectin, vitronectin, von Willebrand factor, or the or,/~, 
or-g chains of fibronectin, these regions are quite short, aver- 
aging 9.6  5= 0.6 (mean +  SEM) residues in length, within 
which amino acid identity with HSA averages only 5.4 :t: 0.2 
residues (56%) (Xie, Q.-W., and C. Nathan, unpublished ob- 
servations). Neutrophil/32 integrins can bind to denatured 
proteins, including reduced and alkylated bovine serum al- 
bumin (13). This may have accounted for or contributed to 
the efficacy of certain CNBr fragments of HSA. However, 
there is no evidence that native HSA can bind to/~2 integrins 
(13),  and no reason to suspect that all the preparations of 
HSA used in our studies were more denatured than any of 
the control proteins. Finally, the lack of effect of HSA on 
TNF-induced adhesion  of neutrophils  to  matrix  protein- 
coated surfaces argues strongly against a  primary mecha- 
nism of action based on binding to adhesion receptors. The 
experiments reported here support a different and apparently 
novel mechanism for the suppressive effects of HSA, as dis- 
cussed below. 
H. Regulation of  CeU Spreading by CD43 
The second conclusion of this work is that CIM3 acts as an 
anti-spreading molecule on PMN.  Thus, stimulus-induced 
spreading of neutrophils, and functional responses of the 
cells that depend on spreading, are closely linked to the abil- 
ity of the cells to desialylate and/or shed CIM3. 
The 234 amino acids of the extracellular portion of human 
CD43 are subject to the addition of up to 85 O-linked carbo- 
hydrate chains (50), the number and nature of which depend 
on the type of cell and its state of differentiation (17). On rat 
T cells, CIM3 has an extended conformation in which the 
extracellular domain protrudes 45 nm from the plasma mem- 
brane (11), farther than expected for any molecule on the sur- 
face of these cells. If this pertains to human PMN, on which 
CIM3 evidently bears most of the sialic acid (Fig. 6), it is 
likely that CD43 mediates the first encounters a resting neu- 
trophil makes with a supramolecular surface. The extraordi- 
nary length, negativity (pI =  4.1) and rigidity of CIM3 (50) 
make it plausible that for integrins and other adhesion mole- 
cules to mediate the  subsequent flattening of neutrophils 
against other cells or extracellular matrix, neutrophils must 
first shed, desialylate, and/or redistribute CIM3 away from 
points of contact. On rat thymocytes and basophilic leuke- 
mia  cells,  CIM3  colocalizes  in  microvilli  with  actin- 
associated proteins of the ezrin-radixin-moesin family and is 
redistributed into the cleavage furrow during mitosis (68). 
Similarly, CIM3 on the neutrophil may redistribute to permit 
the rapid formation of limited intercellular contacts, before 
the cell commits to the more time-consuming and less read- 
ily reversible processes of trimming CD43 or cleaving it. 
The physiologic functions of CD43 are unknown. On lyre- 
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binding of lymphocyte  function associated molecule-1 (LFA- 
1) to intercellular adhesion moleculeq  (ICAM-1,  CD54). 
Cross-linking of CD43 on lymphocytes (46) and monocytes 
(44) can deliver an activation signal, but apparently not on 
neutrophils (29, 32). Functional deficits are evident in lym- 
phoid and myeloid ceils from patients with Wiskott-Aldrich 
syndrome, whose ceils are CD43-deficient when studied ex 
vivo (50).  These deficiencies include the chemotactic re- 
sponse of neutrophils to complement component C5a (45). 
However,  the CD43 gene is unaffected in Wiskott-Aldrich 
syndrome, and cell lines established from these patients ex- 
press CD43 normally in vitro (38). 
Normal human plasma contains >10  gg/ml of a  mucin 
whose apparent molecular mass, carbohydrate composition 
and amino acid sequence match those of  the extracellular do- 
main of an isoform of CD43 that is expressed primarily on 
neutrophils and activated T  lymphocytes (59).  Since acti- 
vated T cells are not known to shed CD43, neutrophils are 
the leading candidate for the origin of the soluble CD43 in 
the circulation. The functions of soluble CD43 are unknown. 
Anti-CD43 antibodies circulate in many patients infected 
with HIV  (2).  If such antibodies act like the anti-CD43 
mAbs  studied here,  they may make  it difficult for HIV- 
infected people to mount a normal inflammatory response. 
IlL Mechanism of  Action of  liSA 
Finally, we conclude that HSNs  action as an antagonist of 
stimulus-induced spreading of neutrophils can be explained 
by its ability to bind to CD43 and diminish the susceptibility 
of CIM3 to sialylytic and proteolytic attack. This represents 
a novel regulatory system of surprising complexity, in which 
a serum protein inhibits cell spreading by preventing cells 
from inactivating a cell-bound antagonist of spreading. 
The notion that HSA can bind CD43 receives support from 
the recent characterization of a receptor used by microvascu- 
lar endothelial cells for transcytosis of albumin (61). The 
gpt0 albumin receptor is a glycoprotein bearing predomi- 
nantly O-linked sialic acid residues (61). In these respects, 
gp60 resembles CD43. This resemblance, and the ability of 
sialidase to blunt the inhibitory effects of HSA on neutrophils 
(Fig. 5), suggest that HSA may bind to CD43 and gp60 via 
their sialyl groups. It is not clear what structural features of 
HSA (37) may confer this putative lectin activity. Nor is it 
known whether CD43 and gp60 are related at the level of 
their core polypeptides. 
The endogenous enzymes responsible for removing CD43 
from stimulated neutrophils have not been identified. Nor 
has it been explained why PMA caused more extensive shed- 
ding of CD43 than TNF, and did so in a manner resistant to 
inhibition by HSA. Three possibilities can be entertained. 
First,  PMA may elicit the release of the same CD43- 
degrading enzymes as TNF but in greater amounts, against 
which HSA may be relatively ineffective. Second, PMA may 
lead to the release of a different set of enzymes than TNF. 
Neutrophil elastase can cleave CD43 (Fig. 7), and the serine 
protease  inhibitor  DFP  can  partially  antagonize  TNF- 
induced shedding of CD43  (Fig.  7,  and Nathan,  C.,  and 
W. W. Jin, unpublished observations). Thus elastase or the 
related serine proteases cathepsin G and protease 3 (6) may 
account for a portion of the shedding elicited by TNE These 
proteases may interact synergistically with endogenous siali- 
dase (51). However, DFP did not block shedding induced by 
PMA. Thus, a DFP-resistant protease may be involved with 
both TNF and PMA as stimuli, playing a predominant role 
with PMA.  Calpain released from sonicated platelets is a 
DFP-resistant protease that can specifically cleave desialy- 
lated CD43 from T lymphocytes (53), and neutrophils con- 
tain calpain (48).  However, the apparent molecular mass of 
the cleavage product left behind by calpain (88 kD) (53) sug- 
gests that the released fragment could not exceed 62 kD. This 
is much smaller than the fragment recovered from the me- 
dium of PMA-activated neutrophils either by immunoprecip- 
itation (32, 55) or by HSA-affinity chromatography ("~125 
kD; Fig.  10). 
Finally, in human blood mononuclear cells and platelets, 
PMA induces hyperphosphorylation  of serine residues in the 
cytoplasmic domain of  CD43 (9, 47). Hyperphosphorylation 
of the cytoplasmic domain of CD43 might affect the inter- 
molecular associations of the extracellular domains, for ex- 
ample, by preventing them from clustering with each other 
or with distinct molecules to which they normally bind, such 
as the Clq receptor (22). Altered intermolecular interactions 
of CD43 extracellular domains could enhance their suscepti- 
bility to hydrolases and/or diminish their ability to bind 
HSA. 
Summary 
Activation of neutrophils involves extensive remodeling of 
the cell surface with respect to molecules that affect adhesion 
and spreading. ~2 integrins are brought forth (4, 29), while 
L-selectin (29) and CIM3 (7, 32, 55; Fig. 7) are let go. How 
these processes are regulated and coordinated is not under- 
stood. The present findings suggest that adherence of neutro- 
phils is a prerequisite for physiologic stimuli to induce shed- 
ding of CD43,  while shedding of CD43  appears  tO be a 
prerequisite  for  neutrophils  to  spread  and  release  large 
amounts of oxidants in response to the same stimuli. That 
HSA, the most abundant plasma protein, can suppress the 
shedding of CD43  suggests the importance to the host of 
controlling when,  where  and to  what extent neutrophils 
spread. 
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